The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05681884
Recruitment Status : Active, not recruiting
First Posted : January 12, 2023
Last Update Posted : April 19, 2024
Genentech, Inc.
Information provided by (Responsible Party):
Greater Houston Retina Research

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 20, 2026
Estimated Study Completion Date : April 13, 2026